CIK 0001806310
- Non-accelerated filer
- Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843199512
- Phone
- +1 214-612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-23 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2020-09-23 | Nagendran Sukumar Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2020-09-23 | Manning Paul B Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2020-09-23 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2020-09-23 | Alam Kamran Chief Financial Officer | Grant or award | +331,121 | 331,121 |
Page 10 of 10 · 185 trades